Pillstats
Rx only · Tablet, Film Coated, Extended Release · Oral

Ropinirole

Ropinirole Hydrochloride

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US20 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN04BC04
RxCUI (US)72302
US makers3 labelers
Packages83
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 25 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.285$0.570$0.855$1.14Dec 2025Apr 2026Jul 2026
$0.959
Latest avg · Jul 22, 2026
+10%
Since Dec 17, 2025
3
Active US suppliers
90%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5861.2K1.8K2.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.7K
Rx · 2026 Q1
84K
Units dispensed
-14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown60SUPPLYING
Dr.Reddy's laboratories Limitedunknown15SUPPLYING
Actavis Pharma, Inc.unknown8SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.